TTX Tetratherix Limited
Healthcare · Biotechnology
· website
· 15 employees
$7.70
52wk 3.09 – 8.08
Overall
—
Value
—
Growth
—
Health
—
Quality
—
Momentum
—
Dividend
—
Price
About Tetratherix Limited
Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical device in the areas of bone regeneration, tissue spacing, and tissue healing applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.
Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$408.38M
P/E (trailing)
—
P/E (forward)
-51.12
EPS (trailing)
-0.40
Dividend yield
—
Payout ratio
0.0%
Beta
—
EV / EBITDA
-49.42
Price / Book
15.91
ROE
-150.0%
Operating margin
-339.9%
Net margin
0.0%
Total cash
$21.56M
Total debt
$11.21M
Current ratio
12.13
Debt / Equity
0.46
Free cash flow
$-9.97M
Avg volume
20,433
Latest annual results
(FY ending 30 Jun 2025)
- Revenue—
- Gross profit—
- Operating income-$6.90M
- Net income-$9.43M
- Diluted EPS-0.36
- Free cash flow-$3.27M
- Net debt-$27.30M